Stuart Rich
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiology and Cardiovascular Medicine top 0.05%
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Pulmonary Hypertension Research and Treatments 137
-
- Cardiovascular Issues in Pregnancy 30
- Cardiovascular Function and Risk Factors 29
- Heart Failure Treatment and Management 19
- Cardiac Valve Diseases and Treatments 8
- Co-authors
- Vallerie V. McLaughlin (24 shared papers)Bruce H. Brundage (20 shared papers)Elizabeth Kaufmann (8 shared papers)Robyn J. Barst (10 shared papers)P. S. Levy (2 shared papers)Lewis J. Rubin (7 shared papers)Stephen L. Archer (18 shared papers)Mardi Gomberg‐Maitland (17 shared papers)
- Journals
- CHEST Journal (26 papers)Journal of the American College of Cardiology (22 papers)The American Journal of Cardiology (17 papers)Circulation (16 papers)American Heart Journal (8 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Stuart Rich
186 papers receiving 23.2k citations
Stuart Rich's Hit Papers
Peers
Comparison fields: 5 of 139
- Pulmonary and Respiratory Medicine 19.1k
- Cardiology and Cardiovascular Medicine 10.9k
- Hepatology 2.1k
- Genetics 2.7k
- Internal Medicine 437
Countries citing papers authored by Stuart Rich
This map shows the geographic impact of Stuart Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Rich more than expected).
Fields of papers citing papers by Stuart Rich
This network shows the impact of papers produced by Stuart Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Rich. The network helps show where Stuart Rich may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Rich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survival in Patients with Primary Pulmonary Hypertension Hit paper breakdown → | 1991 | 2772 |
| 2 | A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension Hit paper breakdown → | 1996 | 2103 |
| 3 | Primary Pulmonary Hypertension Hit paper breakdown → | 1987 | 1599 |
| 4 | Clinical classification of pulmonary hypertension Hit paper breakdown → | 2004 | 1413 |
| 5 | The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension Hit paper breakdown → | 1992 | 1156 |
| 6 | Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial Hit paper breakdown → | 2002 | 1107 |
| 7 | Survival in Primary Pulmonary Hypertension Hit paper breakdown → | 2002 | 949 |
| 8 | Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension Hit paper breakdown → | 1996 | 887 |
| 9 | Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension Hit paper breakdown → | 1998 | 521 |
| 10 | 1996 | 391 | |
| 11 | Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 389 |
| 12 | 2009 | 372 | |
| 13 | Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Hit paper breakdown → | 1989 | 363 |
| 14 | 2007 | 345 | |
| 15 | 2007 | 315 | |
| 16 | 2001 | 315 | |
| 17 | 2000 | 305 | |
| 18 | 1987 | 288 | |
| 19 | 2010 | 276 | |
| 20 | 1995 | 269 |
About Stuart Rich
Stuart Rich is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 194 papers that have together received 24.5k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (137 papers), Cardiovascular Issues in Pregnancy (30 papers), Cardiovascular Function and Risk Factors (29 papers), Heart Failure Treatment and Management (19 papers), Cardiac Imaging and Diagnostics (15 papers), Liver Disease and Transplantation (11 papers), Vascular Anomalies and Treatments (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (19.1k citations), Cardiology and Cardiovascular Medicine (10.9k citations), Hepatology (2.1k citations), Genetics (2.7k citations) and Internal Medicine (437 citations). Stuart Rich has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Vallerie V. McLaughlin, Bruce H. Brundage, Elizabeth Kaufmann, Robyn J. Barst, P. S. Levy, Lewis J. Rubin, Stephen L. Archer, Mardi Gomberg‐Maitland, Alicia C. Shillington and Gérald Simonneau. Their work appears in journals such as CHEST Journal, Journal of the American College of Cardiology, The American Journal of Cardiology, Circulation and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.